Skip to main content
  • ESC: BMS Mostly On Par With DES Long-Term But a few outcomes still favor drug-eluting stents

    ROME — Bare metal stents (BMS) and drug-eluting stents (DES) were neck and neck for several key clinical outcomes in the long run, according to the NORSTENT trialists.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details